Correlation Between Mineralys Therapeutics, and Nurix Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Nurix Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Nurix Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Nurix Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Nurix Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Nurix Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Nurix Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and Nurix Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mineralys and Nurix is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Nurix Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nurix Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Nurix Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nurix Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Nurix Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Nurix Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Nurix Therapeutics. In addition to that, Mineralys Therapeutics, is 1.73 times more volatile than Nurix Therapeutics. It trades about -0.14 of its total potential returns per unit of risk. Nurix Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest 1,951 in Nurix Therapeutics on November 2, 2024 and sell it today you would earn a total of 51.00 from holding Nurix Therapeutics or generate 2.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Nurix Therapeutics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Nurix Therapeutics |
Mineralys Therapeutics, and Nurix Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Nurix Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and Nurix Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Nurix Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nurix Therapeutics will offset losses from the drop in Nurix Therapeutics' long position.| Mineralys Therapeutics, vs. Dine Brands Global | Mineralys Therapeutics, vs. El Pollo Loco | Mineralys Therapeutics, vs. Flanigans Enterprises | Mineralys Therapeutics, vs. Saia Inc |
| Nurix Therapeutics vs. Foghorn Therapeutics | Nurix Therapeutics vs. Shattuck Labs | Nurix Therapeutics vs. Monte Rosa Therapeutics | Nurix Therapeutics vs. Kymera Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |